What is Neomorph?
Neomorph is a venture-backed biotechnology company headquartered in San Diego, California. The company is dedicated to advancing the science of targeted protein degradation, a novel approach to drug discovery. By leveraging proprietary technology and the expertise of its industry-leading scientists, Neomorph aims to create transformative treatments for critical unmet medical needs. Their focus on molecular glues and protein degradation positions them at the forefront of developing therapies for challenging diseases, with a commitment to a patient-first, science-driven methodology.
How much funding has Neomorph raised?
Neomorph has raised a total of $209M across 2 funding rounds:
Series A
$109M
Series B
$100M
Series A (2020): $109M with participation from Deerfield Communications Inc
Series B (2026): $100M led by Regeneron Ventures, Alexandria, Longwood Fund, and Deerfield
Key Investors in Neomorph
Deerfield Communications Inc
Deerfield Communications Inc is an investor in the biotechnology sector, likely focusing on companies with innovative therapeutic approaches. Their participation in Neomorph's funding round suggests a strategic interest in advancing drug discovery.
Regeneron Ventures
Regeneron Ventures is the investment arm of Regeneron Pharmaceuticals, focusing on early-stage biotechnology and pharmaceutical companies. They support the development of groundbreaking therapies and technologies within the life sciences sector.
Alexandria
Alexandria Real Estate Equities, Inc. is a real estate investment trust specializing in properties for the life sciences industry, providing lab and R&D space. Their investment indicates support for companies advancing scientific research and development.
What's next for Neomorph?
The recent major strategic investment signals a pivotal growth phase for Neomorph, likely enabling the company to accelerate its drug discovery and clinical development pipelines. This substantial capital infusion, contributing to the overall $209M raised, will empower Neomorph to further its mission of tackling undruggable targets and bringing novel medicines to patients. The company's focus on innovation and its strong scientific foundation suggest a trajectory aimed at significant advancements in the biotechnology sector.
See full Neomorph company page
